262 related articles for article (PubMed ID: 29563616)
1. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
[TBL] [Abstract][Full Text] [Related]
2. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.
Chang NH; Li TT; Kim JJ; Landolt-Marticorena C; Fortin PR; Gladman DD; Urowitz MB; Wither JE
J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471
[TBL] [Abstract][Full Text] [Related]
3. Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.
Dieudonné Y; Gies V; Guffroy A; Keime C; Bird AK; Liesveld J; Barnas JL; Poindron V; Douiri N; Soulas-Sprauel P; Martin T; Meffre E; Anolik JH; Korganow AS
J Autoimmun; 2019 Aug; 102():150-158. PubMed ID: 31085070
[TBL] [Abstract][Full Text] [Related]
4. Interferon
Akita K; Yasaka K; Shirai T; Ishii T; Harigae H; Fujii H
Front Immunol; 2020; 11():498703. PubMed ID: 33633721
[TBL] [Abstract][Full Text] [Related]
5. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
6. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
[TBL] [Abstract][Full Text] [Related]
7. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.
Båve U; Alm GV; Rönnblom L
J Immunol; 2000 Sep; 165(6):3519-26. PubMed ID: 10975873
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
9. B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM
Arthritis Rheumatol; 2020 May; 72(5):769-779. PubMed ID: 31804007
[TBL] [Abstract][Full Text] [Related]
10. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
11. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
12. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
13. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
[TBL] [Abstract][Full Text] [Related]
14. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
16. Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.
Hamilton JA; Wu Q; Yang P; Luo B; Liu S; Li J; L Mattheyses A; Sanz I; Chatham WW; Hsu HC; Mountz JD
J Immunol; 2018 Oct; 201(8):2203-2208. PubMed ID: 30201809
[TBL] [Abstract][Full Text] [Related]
17. High
Wang T; Marken J; Chen J; Tran VB; Li QZ; Li M; Cerosaletti K; Elkon KB; Zeng X; Giltiay NV
Front Immunol; 2019; 10():1243. PubMed ID: 31231380
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.
Palanichamy A; Bauer JW; Yalavarthi S; Meednu N; Barnard J; Owen T; Cistrone C; Bird A; Rabinovich A; Nevarez S; Knight JS; Dedrick R; Rosenberg A; Wei C; Rangel-Moreno J; Liesveld J; Sanz I; Baechler E; Kaplan MJ; Anolik JH
J Immunol; 2014 Feb; 192(3):906-18. PubMed ID: 24379124
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
20. Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
Yang L; Zhang T; Wang P; Chen W; Liu W; He X; Zhang Y; Jin S; Luo Z; Zhang Z; Wang X; Liu J
Cell Biol Toxicol; 2023 Dec; 39(6):3287-3304. PubMed ID: 37804401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
